Delivery Order SPE2DB20D3104-SPE2DB25FV9M2
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $9.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Ondansetron ODT 4 mg, a commonly used anti-nausea medication, under a firm fixed-price contract valued at $1,842.70. The contract, which became effective on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order was competitively awarded...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 MG, with a ceiling value of $13,338.54 under a firm fixed-price contract type. The delivery order was competitively awarded without set-aside provisions and has an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $26,378.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and veteran healthcare settings. The contract, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will...
- The Defense Logistics Agency awarded a $3,734.63 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Ondansetron ODT 4 mg on July 26, 2025, with completion expected by July 28, 2025. This competitive award, issued under firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, a pharmaceutical product commonly used for nausea and vomiting management in clinical and military healthcare settings. Valued at $7,964.61 with a firm fixed price structure, this non-set-aside competitive award was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract represents a child order under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,849.46 to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, with an ultimate completion date of August 11, 2025. This non-competitive delivery order was issued on August 8, 2025, with firm fixed pricing. The award represents a routine pharmaceutical procurement through AmerisourceBergen's established supply chain, with performance to be executed at the company's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a $33,081.12 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $8,001.71. This is a firm fixed price, non-competitive delivery order executed under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $41,840.90 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Ondansetron HCl 4 mg, an antiemetic medication commonly used in medical and surgical settings. The contract, awarded on July 25, 2025, carries a firm fixed price and requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a $6,475.18 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on July 28, 2025, with completion targeted for July 29, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...